Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check6 days agoChange DetectedLocations section updated with new site entries across multiple countries (California, Connecticut, Illinois, Ohio, Oregon, Pennsylvania, Italy, New Zealand, Eastern Cape, Turkey). Revision tag updated to v3.3.3.SummaryDifference1.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1, which is a cosmetic metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.1, with no changes to study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedAn administrative banner regarding government funding and NIH operating status, previously shown on the study page, has been removed.SummaryDifference0.3%

- Check56 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the page text and structure appear unchanged.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a prominent operating-status notice and a new v3.2.0 revision; removed the previous v3.1.0. This signals a status update and version upgrade.SummaryDifference2%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.